Contact your GP if you experience: New or worsening symptoms suggesting thyroid dysfunction, such as extreme fatigue, significant unintended weight changes, palpitations, anxiety, or depression Persistent gastrointestinal side effects from GLP-1 medications that interfere with taking levothyroxine appropriately Neck swelling, pain, difficulty swallowing or persistent hoarseness , which could indicate thyroid changes requiring assessment, potentially via urgent suspected cancer pathways if concerning features are present Symptoms of hypoglycaemia (if you have diabetes), particularly if you take other glucose-lowering medications alongside GLP-1 therapy Severe, persistent abdominal pain (with or without vomiting), which could indicate pancreatitis requiring urgent medical attention Right upper abdominal pain, fever, or yellowing of the skin or eyes , which might suggest gallbladder problems, a known risk with GLP-1 medications and rapid weight loss New or worsening visual symptoms if you have diabetic retinopathy, as rapid improvement in blood glucose can sometimes temporarily worsen retinopathy [19] [20] Regular medication reviews are essential

The book can also include "From the library of" labels
Feb 26, 2026 Your stomach feels like a balloon
Most people who think that the discovery of a protein target is when the drug is born, have not idea about drug discovery
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical